סימבקסון 40

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

SIMVASTATIN

Disponibil de la:

DEXCEL PHARMA TECHNOLOGIES LTD

Codul ATC:

C10AA01

Forma farmaceutică:

קפליות

Compoziție:

SIMVASTATIN 40 MG

Calea de administrare:

פומי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

DEXCEL LTD, ISRAEL

Grupul Terapeutică:

SIMVASTATIN

Zonă Terapeutică:

SIMVASTATIN

Indicații terapeutice:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

Rezumat produs:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

Data de autorizare:

2020-04-30